GTCM
RGNX icon

Gyon Technologies Capital Management’s Regenxbio RGNX Stock Holding History

Gyon Technologies Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,219
Closed -$623K – 568
2022
Q2 		$623K Buy
25,219
+18,327
+266% +$458K 0.17% 148
2022
Q1 		$229K Sell
6,892
-86,437
-93% -$2.4M 0.16% 218
2021
Q4 		$3.05M Buy
+93,329
New +$3.18M 0.56% 34
2021
Q3 		– Sell
-6,257
Closed -$243K – 470
2021
Q2 		$243K Buy
+6,257
New +$224K 0.08% 310
2021
Q1 		– Sell
-7,234
Closed -$328K – 493
2020
Q4 		$328K Buy
+7,234
New +$253K 0.11% 240

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Gyon Technologies Capital Management's RGNX Position: Q3 2022 in Review

Gyon Technologies Capital Management sold out of Regenxbio (RGNX) in Q3 2022, closing a stake of 25,219 shares — an estimated $623K sold.

Gyon Technologies Capital Management first reported a position in RGNX in Q4 2020 and held it in 5 quarters. The position peaked at $3.05M in Q4 2021. 183 funds tracked by Wall St. Rank hold RGNX as of Q3 2022.

  • Gyon Technologies Capital Management reported no remaining Regenxbio position as of Q3 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 25,219 Regenxbio shares in Q3 2022, an estimated $623K.
  • Gyon Technologies Capital Management first reported a position in Regenxbio in Q4 2020 and held it in 5 quarters.
  • Gyon Technologies Capital Management's Regenxbio position peaked at $3.05M in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Regenxbio as of Q3 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.